| Elanco Animal Health Inc (ELAN) | |||
|---|---|---|---|
| 19.91 0.47 (2.42%) | 08-08 16:00 | ||
| Open: | 19.59 | Pre. Close: | 19.44 |
| High: | 20.46 | Low: | 19.3 |
| Volume: | 10,571,382 | Market Cap: | 9,439M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 20.495 - 20.593 | 20.593 - 20.682 |
| Low: | 19.065 - 19.176 | 19.176 - 19.277 |
| Close: | 19.725 - 19.91 | 19.91 - 20.077 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 24.49 One year: 28.61 |
| Support: | Support1: 19.53 Support2: 18.64 |
| Resistance: | Resistance1: 20.97 Resistance2: 24.49 |
| Pivot: | 20.10  |
| Moving Averages: | MA(5): 19.42 MA(20): 20.04 MA(100): 23.00 MA(250): 27.10 |
| MACD: | MACD(12,26): -0.36 Signal(12,26,9): -0.34 |
| %K %D: | %K(14,3): 32.43 %D(3): 20.39 |
| RSI: | RSI(14): 45.86 |
| 52-Week: | High: 35 Low: 18.64 Change(%): -36.9 |
| Average Vol(K): | 3-Month: 4543 10-Days: 6075 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ELAN ] has closed above bottom band by 41.7%. Bollinger Bands are 23.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers—Specialty & Generic | |
| Shares Out. (M) | 474.10 |
| Shares Float (M) | 426.08 |
| % Held by Insiders | 4.13 |
| % Held by Institutions | 106.60 |
| Shares Short (K) | 14740 |
| Shares Short Prior Month (K) | 17550 |
| Stock Financials | |
|---|---|
| EPS | -0.750 |
| Book Value (p.s.) | 16.060 |
| Profit Margin | -7.64 |
| Operating Margin | 9.75 |
| Return on Assets (ttm) | 1.7 |
| Return on Equity (ttm) | -4.7 |
| Qtrly Rev. Growth | -1.4 |
| Gross Profit (p.s.) | 5.674 |
| Sales Per Share | 10.019 |
| EBITDA (p.s.) | 2.320 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 399.00 |
| Levered Free Cash Flow (M) | 539.50 |
| Stock Valuation | |
|---|---|
| PE Ratio | -26.55 |
| PEG Ratio | 1.32 |
| Price to Book value | 1.24 |
| Price to Sales | 1.99 |
| Price to Cash Flow | 23.66 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
